van der Donk W A, Zeng C, Biemann K, Stubbe J, Hanlon A, Kyte J
Department of Chemistry, Massachusetts Institute of Technology, Cambridge 02139, USA.
Biochemistry. 1996 Aug 6;35(31):10058-67. doi: 10.1021/bi952869d.
Incubation of the C225S mutant of the R1 subunit of ribonucleotide reductase from Escherichia coli with the R2 subunit and nucleoside diphosphates leads to fragmentation of the polypeptide backbone of R1 [Mao, S. S., Holler, T. P., Bollinger, J.M., Jr., Yu, G. X., Johnston, M.I., & Stubbe, J. (1992) Biochemistry 31, 9744--9751]. The 26 and 60 kDa cleavage fragments were purified to homogeneity. The 26 kDa polypeptide was digested with Lys-C, and the peptides were partially purified by RP-HPLC. Mass spectrometric analysis (MALDI-TOF) of the HPLC fractions allowed the identification of the C-terminal peptide. The molecular mass of this peptide (2176) revealed that serine-224 constitutes its C-terminus, and further analysis of the distribution of its monoisotopic masses by FAB-MS indicated that Ser224 possesses a carboxamide rather than a carboxylate group. Treatment of the 60 kDa cleavage fragment with cyanogen bromide and subsequent MALDI-TOF analysis of the partially RP-HPLC purified peptides yielded a fraction containing its N-terminal peptide. This peptide was digested with trypsin, and the digestion mixture was purified by HPLC. Analysis of the fractions by MALDI-TOF identified the N-terminal peptide and determined a mass of 2222. This mass suggested valine 226 was the N-terminal residue (modified by an adduct of 28 mass units). Larger amounts of the C-terminal tetrapeptide of the 60 kDa fragment (V226LIE229) were obtained by complete digestion of the crude reaction mixture with endoproteinase Glu-C. The peptide mixture was then purified on an immunoadsorbent column containing immobilized antibodies raised against a synthetic peptide with the sequence KVLIE. After elution of the affinity-bound peptide, it was analyzed by CID-MS verifying that an adduct of 28 mass units was attached to valine 226. These results indicated that the amino group of Val226 is formylated. The localization of the residues at the cleavage site of C225SR1 provides a biochemical identification of the active site region of the R1 subunit of RDPR from E.coli. The details of the mechanism of cleavage remain to be elucidated.
将来自大肠杆菌的核糖核苷酸还原酶R1亚基的C225S突变体与R2亚基及核苷二磷酸一起温育,会导致R1的多肽主链断裂[毛,S.S.,霍勒,T.P.,博林格,J.M.,Jr.,于,G.X.,约翰斯顿,M.I.,& 斯塔布,J.(1992年)《生物化学》31卷,9744 - 9751页]。将26 kDa和60 kDa的裂解片段纯化至均一。用Lys - C消化26 kDa的多肽,并用反相高效液相色谱(RP - HPLC)对肽段进行部分纯化。对HPLC级分进行基质辅助激光解吸电离飞行时间质谱(MALDI - TOF)分析,从而鉴定出C末端肽段。该肽段的分子量(2176)表明丝氨酸 - 224构成其C末端,通过快原子轰击质谱(FAB - MS)对其单同位素质量分布的进一步分析表明,Ser224具有羧酰胺基团而非羧酸盐基团。用溴化氰处理60 kDa的裂解片段,随后对经RP - HPLC部分纯化的肽段进行MALDI - TOF分析,得到一个含有其N末端肽段的级分。用胰蛋白酶消化该肽段,并用HPLC对消化混合物进行纯化。通过MALDI - TOF对级分进行分析,鉴定出N末端肽段并确定其质量为2222。该质量表明缬氨酸226是N末端残基(被一个28质量单位的加合物修饰)。通过用内肽酶Glu - C完全消化粗反应混合物,获得了更多量的60 kDa片段的C末端四肽(V226LIE229)。然后将肽混合物在含有针对序列为KVLIE的合成肽产生的固定化抗体的免疫吸附柱上进行纯化。洗脱亲和结合的肽段后,通过碰撞诱导解离质谱(CID - MS)对其进行分析,证实28质量单位的加合物连接在缬氨酸226上。这些结果表明缬氨酸226的氨基被甲酰化。C225SR1裂解位点处残基的定位为来自大肠杆菌的核糖核苷酸二磷酸还原酶R1亚基的活性位点区域提供了生化鉴定。裂解机制的细节仍有待阐明。